By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Relmada Therapeutics 

  New York    U.S.A.
Phone: n/a Fax: n/a


Company News
Relmada Therapeutics To Present At The 18th Annual BIO CEO & Investor Conference 2/2/2016 9:04:40 AM
Relmada Therapeutics Files Amended Complaint Against Laidlaw And Its Principals, Matthew Eitner And James Ahern 1/26/2016 6:19:37 AM
Relmada Therapeutics Selected To Present At 2016 Biotech Showcase In San Francisco 1/11/2016 11:31:35 AM
Relmada Therapeutics Successfully Completes Multiple Ascending Dose Study Of D-Methadone For Neuropathic Pain 1/4/2016 6:26:49 AM
Relmada Therapeutics Announces Results Of Annual Meeting Of Stockholders 12/30/2015 11:10:01 AM
Relmada Therapeutics Recommends Stockholders Vote "FOR" Relmada's Director Nominees on the WHITE Proxy Card Today 12/28/2015 7:29:21 AM
Relmada Therapeutics Sends Letter To Stockholders Highlighting Significant Progress In Value Creation Strategy Overseen By Board And Management Team 12/21/2015 8:42:25 AM
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Relmada Therapeutics Stockholders Vote The WHITE Proxy Card "FOR" Relmada's Director Nominees: Shreeram Agharkar And Maged Shenouda 12/15/2015 10:20:51 AM
Pharmaceutical Industry Leader James Dolan Joins Relmada Therapeutics Advisory Team 12/14/2015 8:13:28 AM
Relmada Therapeutics Files Federal Lawsuit Against Laidlaw & Company And Its Principals Matthew Eitner And James Ahern To Protect Interests Of Relmada Stockholders 12/9/2015 8:31:02 AM